Interaction of the human protein kinase PKR with the mouse PKR homolog occurs via the N-terminal region of PKR and does not inactivate autophosphorylation activity of mouse PKR

Virology

Volumn 238, Issue 2, 1997, Pages 410-423

  Rende Fournier, Rosanna ^a   Ortega, Laura G ^a   George, Cyril X ^a   Samuel, Charles E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; PROTEIN KINASE;

AMINO TERMINAL SEQUENCE; ANTIVIRAL ACTIVITY; ARTICLE; AUTOPHOSPHORYLATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; VIRUS CELL INTERACTION; VIRUS INFECTION;

EID: 0031585534     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8824     Document Type: Article

References (68)

1. Baier L. J., Shors G., Shors S. T., Jacobs B. L. The mouse phosphotyrosine kinase, TIK, is indistinguishable from the double-stranded RNA-dependent, interferon-induced protein kinase PKR. Nucleic Acis Res. 21:1993;4830-4835.
2. Barber G. N., Wambach M., Wong M. L., Dever T. E., Hinnebusch A. G., Katze M. G. Translational regulation by the interferon-induced double-stranded-RNA-activated 68-kDa protein kinase. Proc. Natl. Acad. Sci. USA. 90:1993;4621-4625.
3. Barber G. N., Thompson S., Lee T. G., Strom T., Jagus R., Darveau A., Katze M. G. The 58-kilodalton inhibitor of the interferon-induced double-stranded RNA-activated protein kinase is a tetratricopeptide repeat protein with oncogenic properties. Proc. Natl. Acad. Sci. USA. 91:1995a;4278-4282.
4. Barber G. N., Wambach M., Thompson S., Jagus R., Katze M. G. Mutants of the RNA-dependent protein kinase (PKR) lacking double-stranded RNA binding domain I can act as transdominant inhibitors and induce malignant transformation. Mol. Cell. Biol. 15:1995b;3138-3146.
5. Benkirane M., Neurveut C., Chun R. F., Smith S. M., Samuel C. E., Gatignol A., Jeang K-T. Oncogenic potential of TAR RNA binding protein TRBP and its regulatory interaction with RNA-dependent protein kinase PKR. EMBO J. 16:1997;611-624.
6. Berry M. J., Knutson G. S., Lasky S. R., Munemitsu S. M., Samuel C. E. Purification and substrate specificities of the double-stranded RNA-dependent protein kinase from untreated and interferon-treated mouse fibroblasts. J. Biol. Chem. 260:1985;11240-11247.
7. Bevilacqua P. C., Cech T. R. Minor-groove recognition of double-stranded RNA by the double-stranded RNA-binding domain from the RNA-activated protein kinase PKR. Biochemistry. 35:1996;9983-9994.
8. Bischoff J. R., Samuel C. E. Mechanism of interferon action: The interferon-induced phosphoprotein P1 possesses a double-stranded RNA-dependent ATP-binding site. J. Biol. Chem. 260:1985;8237-8239.
9. Carpick B. W., Graziano V., Schneider D., Maitra R. K., Lee X., Williams B. R. G. Characterization of the solution complex between the interferon-induced, double-stranded RNA-activated protein kinase and HIV-I trans-activating region RNA. J. Biol. Chem. 272:1997;9510-9516.
10. Chong K. L., Feng L., Schappert K., Meurs E., Donahue T. F., Friesen J. D., Hovanessian A. G., Williams B. R. Human p68 kinase exhibits growth suppression in yeast and homology to the translational regulator GCN2. EMBO J. 11:1992;1553-1562.
11. Clemens M. J. Protein kinases that phosphorylate eIF-2 and eIF-2B, and their role in eukaryotic cell translational control. Translational Control. 1996;Cold Spring Harbor Laboratory Press, Cold Spring Harbor. p. 139-172.
12. Cosentino G. P., Venkatesan S., Serluca F. C., Green S. R., Mathews M. B., Sonenberg N. Double-stranded-RNA-dependent protein kinase and TAR RNA-binding protein form homo- and heterodimersin vivo. Proc. Natl. Acad. Sci. USA. 92:1995;9445-9449.
13. David M. Transcription factors in interferon signaling. Pharmac. Ther. 65:1995;149-161.
14. Donze O., Jagus R., Koromilas A. E., Hershey J. W. B., Sonenberg N. Abrogation of translation initiation factor eIF-2 phosphorylation causes malignant transformaton of NIH3T3 cells. EMBO J. 14:1995;3828-2834.
15. Durfee T., Becherer K., Chen P-L, Yeh S-H, Yang Y., Kilbur A. E., Lee W-H., Elledge S. J. The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit. Genes Dev. 7:1993;555-569.
16. Fields S., Song O-k. A novel genetic system to detect protein-protein interactions. Nature. 340:1989;245-247.
17. Galabru J., Hovanessian A. Autophosphorylation of the protein kinase dependent upon double-stranded RNA. J. Biol. Chem. 262:1987;15538-15544.
18. Gale M., Tan S-L., Wambach M., Katze M. G. Interaction of the interferon-induced PKR protein kinase with inhibitory proteins p58 and vaccinia virus K3L is mediated by unique domains: Implications for kinase regulation. Mol. Cell Biol. 16:1996;4172-4181.
19. George C. X., Thomis D. C., McCormack S. J., Svahn C. M., Samuel C. E. Characterization of the heparin-mediated activation of PKR, the interferon-inducible RNA-dependent protein kinase. Virology. 221:1996;180-188.
20. Guan K. L., Dixon J. E. Eukaryotic proteins expressed inEscherichia coli:S. Anal. Biochem. 192:1991;262-267.
21. Henry G. L., McCormack S. J., Thomis D. C., Samuel C. E. Mechanism of interferon action: Translational control of the RNA-dependent protein kinase (PKR) - Antagonists of PKR enhance the translational activity of mRNAs that include a 161 nucleotide region from reovirus S1 mRNA. J. Biol. Regul. Homeost. Agents. 8:1994;15-24.
22. Icely P. L., Gros P., Bergeron J. M., Devault A., Afar D. E., Bell J. C. TIK, a novel serine/threonine kinase, is recognized by antibodies directed against phosphotyrosine. J. Biol. Chem. 266:1991;16073-16077.
23. Jacobs B. L., Langland J. O. When two strands are better than one: The mediators and modulators of the cellular responses to double-stranded RNA. Virology. 219:1996;339-349.
24. Jaramillo M. L., Abraham N., Bell J. C. The interferon system: A review with emphasis on the role of PKR in growth control. Cancer Invest. 13:1995;327-338.
25. Katze M. G. Regulation of the interferon-induced PKR: Can viruses cope? Trends Microbiol. 3:1995;75-78.
26. Kuhen K. L., Samuel C. E. Isolation of the interferon-inducible RNA-dependent protein kinasePkrPkr. Virology. 227:1997;119-130.
27. Kuhen K. L., Shen X., Carlisle E. R., Richardson A. L., Weier H-U. G., Tanaka H., Samuel C. E. Mechanism of interferon action: Structural organization of the humanPkr. Genomics. 36:1996;197-201.
28. Koromilas A. E., Roy S., Barber G. N., Katze M. G., Sonenberg N. Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. Science. 257:1992;1685-1689.
29. Kostura M., Mathews M. B. Purification and activation of the double-stranded RNA-dependent eIF-2 kinase DAI. Mol. Cell. Biol. 9:1989;1576-1586.
30. Kumar A., Haque J., Lacoste J., Hiscott J., Williams B. R. G. Double stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B. Proc. Natl. Acad. Sci. USA. 91:1994;6288-6292.
31. Kumar A., Yang Y-L., Flati V., Der S., Kadereit S., Deb A., Haque J., Reis L., Weissman C., Williams B. R. G. Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: Role of IRF-1 and NF-kB. EMBO J. 16:1997;406-416.
32. Landolfo S., Gribaudo G., Angeretti A., Gariglio M. Mechanisms of viral inhibition by interferons. Pharmac. Ther. 65:1995;415-442.
33. Langland J. O., Jacobs B. L. Cytosolic double-stranded RNA-dependent protein kinase is likely a dimer of partially phosphorylated Mr = 66,000 subunits. J. Biol. Chem. 267:1992;10729-10736.
34. Lee T. G., Tomita J., Hovanessian A. G., Katze M. G. Characterization and regulation of the 58,000-dalton cellular inhibitor of the interferon-induced dsRNA-activated protein kinase. J. Biol. Chem. 267:1992;14238-14243.
35. Lee S. B., Rodriquez D., Rodriquez J. R., Esteban M. The apoptosis pathway triggered by the interferon-induced protein kinase PKR requires the third basic domain, initiates upstream of Bcl-2, and involves ICE-like proteases. Virology. 199:1997;491-496.
36. Lengyel P. Tumor-suppressor genes: News about the interferon connection. Proc. Natl. Acad. Sci. USA. 90:1993;5893-5895.
37. Mathews M. B. Viral evasion of cellular defense mechanisms: Regulation of the protein kinase DAI by RNA effectors. Semin. Virol. 4:1993;247-257.
38. McCormack S. J., Thomis D. C., Samuel C. E. Mechanism of interferon action. Identification of a RNA-binding domain within the N-terminal region of the human RNA-dependent P1/eIF-2α protein kinase. Virology. 188:1992;47-56.
39. McCormack S. J., Ortega L. G., Doohan J. P., Samuel C. E. Mechanism of interferon action: Motif I of the interferon-induced, RNA-dependent protein kinase (PKR) is sufficient to mediate RNA-binding activity. Virology. 198:1994;92-99.
40. McMillian N. A. J., Chun R. F., Siderovski D. P., Galabru J., Toone W. M., Samuel C. E., Mak T. W., Hovanessian A. G., Jeang K-T., Williams B. R. G. HIV-1 Tat directly interacts with the interferon-induced, double-stranded RNA-dependent kinase PKR. Virology. 213:1995;413-424.
41. Meurs E., Chong K., Galabru J., Thomas N. S., Kerr I. M., Williams B. R. G., Hovanessian A. G. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell. 62:1990;379-390.
42. Meurs E. F., Galabru J., Barber G. N., Katze M. G., Hovanessian A. G. Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. Proc. Natl. Acad. Sci. USA. 90:1993;232-236.
43. Ortega L. G., McCotter M. D., Henry G. L., McCormack S. J., Thomis D. C., Samuel C. E. Mechanism of interferon action. Biochemical and genetic evidence for the intermolecular association of the RNA-dependent protein kinase PKR from human cells. Virology. 215:1996;31-39.
44. Park H., Davies M. V., Langland J. O., Chang H. W., Nam Y. S., Tartaglia J., Paoletti E., Jacobs B. L., Kaufman R. J., Venkatesan S. TAR RNA-binding protein is an inhibitor of the interferon-induced protein kinase PKR. Proc. Natl. Acad. Sci. USA. 91:1994;4713-4717.
45. Patel R. C., Stanton P., McMillan N. M. J., Williams B. R. G., Sen G. C. The interferon-inducible double-stranded RNA-activated protein kinase self-associatesin vitroin vivo. Proc. Natl. Acad. Sci. USA. 92:1995;8283-8287.
46. Patterson J. P., Samuel C. E. Expression and regulation by interferon of a double-stranded RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase. Mol. Cell. Biol. 15:1995;5376-5388.
47. Pavlovic J., Schroder A., Blank A., Pitossi F., Staeheli P. Mx proteins: GTPases involved in the interferon-induced antiviral state. Ciba Found. Symp. 176:1993;233-243.
48. Pestka S., Langer J. A., Zoon K. C., Samuel C. E. Interferons and their actions. Annu. Rev. Biochem. 56:1987;727-777.
49. Petryshyn R., Chen J. J., London I. M. Detection of activated double-stranded RNA-dependent protein kinase in 3T3-F442A cells. Proc. Natl. Acad. Sci. USA. 85:1988;1427-1431.
50. Romano P. R., Green S. R., Barber G. N., Mathews M. B., Hinnebusch A. G. Structural requirements for double-stranded RNA binding, dimerization, and activation of the human eIF-2α kinase DAI inSaccharomyces cerevisiae. Mol. Cell. Biol. 15:1995;365-378.
51. Sambrook J., Fritsch E. F., Maniatis G. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
52. Samuel C. E. Mechanism of interferon action: Phosphorylation of protein synthesis initiation factor eIF-2 in interferon-treated human cells by a ribosome-associated protein kinase possessing site-specificity similar to hemin-regulated rabbit reticulocyte kinase. Proc. Natl. Acad. Sci. USA. 76:1979;600-604.
53. Samuel C. E. Antiviral actions of interferon: Interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology. 183:1991;1-11.
54. Samuel C. E. The eIF-2α protein kinases, regulators of translation in eukaryotes from yeasts to humans. J. Biol. Chem. 268:1993;7603-7606.
55. Samuel C. E., Knutson G. S., Berry M. J., Atwater J. A., Lasky S. R. Purification of double-stranded RNA-dependent protein kinase from mouse fibroblasts. Methods Enzymol. 119:1986;499-516.
56. Samuel C. E., Kuhen K. L., George C. X., Ortega L. G., Rende-Fournier R., Tanaka H. The PKR protein kinase- an interferon-inducible regulator of cell growth and differentiation. J. Hematol. 65:1997;227-237.
57. Tanaka H., Samuel C. E. Mechanism of interferon action: Structure of the mouse PKR gene encoding the interferon-inducible RNA-dependent protein kinase. Proc. Natl. Acad. Sci. 91:1994;7995-7999.
58. Taylor D. R., Lee S. B., Romano P. R., Marshak D. R., Hinnebusch A. G., Esteban M., Mathews M. B. Autophosphorylation sites participate in the activation of the double-stranded-RNA-activated protein kinase PKR. Mol. Cell Biol. 16:1996;6295-6302.
59. Thomis D. C., Doohan J. P., Samuel C. E. Mechanism of interferon action: cDNA structure, expression and regulation of the interferon-induced, RNA-dependent PI/eIF-2α protein kinase from human cells. Virology. 188:1992;33-46.
60. Thomis D. C., Samuel C. E. Mechanism of interferon action: Autoregulation of RNA-dependent P1/eIF-2α protein kinase (PKR) expression in transfected mammalian cells. Proc. Natl. Acad. Sci. USA. 89:1992;10837-10841.
61. Thomis D. C., Samuel C. E. Mechanism of interferon action: Evidence for intermolecular autophosphorylation and autoactivation of the interferon-induced, RNA-dependent protein kinase PKR. J. Virol. 67:1993;7695-7700.
62. Thomis D. C., Samuel C. E. Characterization of the intermolecular autophosphorylation of PKR, the interferon-inducible RNA-dependent protein kinase. J. Virol. 69:1995;5195-5198.
63. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA. 76:1979;4350-4354.
64. Vilcek J., Sen G. C. Interferons and other cytokines. Fundamental Virology. 1996;Lippincott-Raven, New York. p. 341-365.
65. Wong A. H-T, Tam N. W. N., Yang Y-L., Cuddihy A. R., Li S., Kirchoff S., Hauser H., Decker T., Koromilas A. E. Physical association between STAT1 and the interferon-inducible protein kinase PKR and implications for interferon and double-stranded RNA signaling pathways. EMBO J. 16:1997;1291-1304.
66. Wu S., Kaufman J. Double-stranded (ds) RNA binding and not dimerization correlates with the activation of the dsRNA-dependent protein kinase (PKR). J. Biol. Chem. 271:1996;1756-1763.
67. Wu S., Kaufman J. A model for the double-stranded RNA (dsRNA)-dependent dimerization and activation of the dsRNA-activated protein kinase PKR. J. Biol. Chem. 272:1997;1291-1296.
68. Yang Y-L., Reis L. F. L., Pavlovic J., Aguzzi A., Schafer R., Kumar A., Williams B. R. G., Aguet M., Weissmann C. Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J. 14:1995;6095-6106.